Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Endocrinology|April 28, 1995
Transforming growth factor beta secretion from primary breast cancer fibroblastsC E van Roozendaal, J G Klijn, B van Ooijen, et al.
International Journal of Cancer|January 3, 1996
Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sourcesK E van Roozendaal, J G Klijn, B van Ooijen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and MetastasisD J Ruiter, C M Ferrier, G N van Muijen, et al.
World Journal of Surgery|March 1, 1997
Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic methodJ Bonnema, A N van Geel, B van Ooijen, et al.
Cancer|November 15, 1994
Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complicationW H Kruit, K J Punt, S H Goey, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parametersV Kuenen-Boumeester, T H Van der Kwast, C C Claassen, et al.
The International Journal of Biological Markers|October 19, 2001
Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissueS van der Flier, T H van der Kwast, C J Claassen, et al.
The Journal of Pathology|November 5, 1999
Altered expression of p53 and its regulated proteins in phyllodes tumours of the breastV Kuenen-Boumeester, S C Henzen-Logmans, M M Timmermans, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot studyM E van der Burg, S C Henzen-Logmans, J A Foekens, et al.
British Journal of Cancer|October 1, 1996
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumoursM Schuyer, I L van Staveren, J G Klijn, et al.
Pageof 8